Committee members disclosed the following financial or other conflicts of interest (COI) covering the period 12 months before December 2022

MemberEmploymentResearch
grant
Other
research
support
Speakers’
bureau/
honoraria
Ownership
interest
Consultant/
advisory board
Other
American Diabetes Association Professional Practice Committee 
Nuha A. ElSayed (Chair)§ American Diabetes Association None None None None Expert, World Health Organization Endocrinologist, Joslin Diabetes Center
Chair, Diabetes Education for All 
Grazia Aleppo Northwestern University Feinberg School of Medicine
Division of Endocrinology, Metabolism and Molecular Medicine 
Dexcom#, Eli Lilly#, Fractyl Health#, Insulet/Self#, Emmes# Emmes, Fractyl, Welldoc Dexcom, Insulet/Self None Bayer, Dexcom, Eli Lilly, Insulet, Medscape Associate Editor, Diabetes Technology & Therapeutics 
Vanita R. Aroda Brigham and Women’s Hospital
Faculty, Harvard Medical School 
Applied Therapeutics#, Eli Lilly#, Fractyl#, Novo Nordisk# None None None Applied Therapeutics, Fractyl, Novo Nordisk*, Pfizer, Sanofi Spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present, Janssen Pharmaceutical Companies of Johnson & Johnson
Consultant/educational activities: Associate Editor, Diabetes Care; Member of the Writing Group for “Management of Hyperglycemia in Type 2 Diabetes, 2022. Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)”
Novo Nordisk* (received other Industry benefits, such as travel) 
Raveendhara R. Bannuru (Chief Methodologist)§ American Diabetes Association None None None None None None 
Florence M. Brown Joslin Diabetes Center None Dexcom None None None None 
Dennis Bruemmer Cleveland Clinic Lerner College of Medicine, Case Western Reserve University Novartis None None None Intellisphere, Esperion (advisory board) HCPLive/sponsored continuing medical education 
Billy S. Collins CDR, U.S. Public Health Service None None None None None None 
Marisa E. Hilliard Baylor College of Medicine Texas Children’s Hospital None JDRF None None None Springer Publishing (book royalties)
Associate Editor, American Psychological Association
Member, Clinical & Research Advisory Committee; College Diabetes Network Member, External Registry & Research Committee; T1D Exchange Mental Health Diabetes Education Program 
Diana Isaacs Cleveland Clinic Endocrinology & Metabolism Institute None None Abbott, Dexcom, Medtronic, Novo Nordisk, Bayer None Insulet, Eli Lilly, Sanofi, Klinio, Undermyfork Board of Directors, Association of Diabetes Care and Education Specialists
Clinical Practice Guideline Oversight Committee, American Association of Clinical Endocrinology 
Eric L. Johnson University of North Dakota School of Medicine and Health Sciences
Altru Health System 
None None None None None Editorial Board, Clinical Diabetes 
Scott Kahan George Washington University Milken Institute School of Public Health
National Center for Weight and Wellness 
None None None None Vivus, Eli Lilly, Novo Nordisk, Currax, Gelesis, Medscape (All without compensation)
Board of Directors, The Obesity Society Board of Directors, Obesity Action Coalition
Advocacy and Public Outreach Core Committee, Endocrine Society 
Kamlesh Khunti University of Leicester
Leicester Diabetes Centre
Leicester General Hospital 
Boehringer Ingelheim#, Applied Therapeutics, AstraZeneca#, Novartis#, Novo Nordisk#, Oramed Pharmaceuticals, Sanofi#, Eli Lilly#, Merck Sharp & Dohme# None None None AstraZeneca, Bayer, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Boehringer Ingelheim None 
Jose Leon National Center for Health in Public Housing None None None None None None 
Sarah K. Lyons Baylor College of Medicine
Texas Medical Center Diabetes and Endocrinology 
None None None Eli Lilly (parent stockholder) None Unpaid Board Member, Epic’s Pediatric Endocrinology Steering Board
Volunteer member, Clinical and Research Advisor Committee of College Diabetes Network
Volunteer member, Publications Committee on the T1D Exchange Quality Improvement Collaborative 
Mary Lou Perry UVA Heart and Vascular Center- Morrison’s Compass Group None None None None LifeScan Diabetes Institute Editorial Board Member, Diabetes Spectrum 
Priya Prahalad Stanford Hospital and Clinics
Lucile Packard Children’s Hospital 
None None None None None Unpaid Board Member on Epic’s Pediatric Endocrinology Steering Board 
Richard E. Pratley Advent Health Translational Research Institute Novo Nordisk# None Novo Nordisk# None Bayer AG#, Gasherbrum Bio#, Hanmi Pharmaceutical#, Hengrui (USA)#, Merck#, Novo Nordisk#, Rivus Pharmaceuticals#, Sun Pharmaceutical Industries# Editorial Board Member, Diabetes Care
Board Member, International Geriatric Diabetes Society 
Jane Jeffrie Seley Weill Cornell Medicine None None None None None Director of Strategy, Diabetes Technology Society
Associate Editor, Diabetes Spectrum
Section Co-editor, Current Diabetes Reports
Editor, Journal of Diabetes Science and Technology
Editor, BMJ Open Diabetes Research & Care
LifeScan Diabetes Institute 
Robert C. Stanton Joslin Diabetes Center None None None None None None 
Robert A. Gabbay§ American Diabetes Association None None None None Onduo*, HealthReveal, Lark, Vida Health* Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association
Senior volunteer, Joslin Diabetes Center 
American College of Cardiology Designated Representatives and Staff (Section 10 “Cardiovascular Disease and Risk Management”) 
Sandeep R. Das University of Texas Southwestern Medical Center None None None None None Associate Editor, Circulation 
Mikhail Kosiborod Saint Luke’s Mid America Heart Institute AstraZeneca#, Boehringer Ingelheim# AstraZeneca# None None Alnylam, Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Cytokinetics, Eli Lilly, Esperion Therapeutics, Janssen#*, Lexicon, Merck (Diabetes and Cardiovascular), Novo Nordisk*#, Pharmacosmos, Sanofi*, Vifor Pharma*None 
American Diabetes Association Staff 
Malaika I. Hill American Diabetes Association None None None None None None 
Laura S. Mitchell American Diabetes Association None None None None None None 
Designated Subject Matter Experts 
Kenneth Cusi University of Florida Echosens#, Inventiva#, Novo Nordisk#, Poxel#, Labcorp#, and Zydus# None None None Altimmune, Arrowhead, AstraZeneca, 89Bio, Bristol-Myers Squibb, Lilly, Madrigal, Merck, Novo Nordisk, ProSciento, Quest, Sagimet Biosciences, Sonic Incytes, Terns None 
Jason L. Gaglia Joslin Diabetes Center Harvard Medical School None None None None None None 
Christopher H. Gibbons Beth Israel Deaconess Medical Center Grifols Grifols None CND Life Sciences None None 
John M. Giurini Beth Israel Deaconess Medical Center None None None None None None 
Lisa Murdock American Diabetes Association None None None None None None 
Jennifer K. Sun Joslin Diabetes Center  Novo Nordisk, Boehringer Ingelheim, Genentech/Roche Jaeb Center for Health Research/National Eye Insitute, JDRF Genentech/Roche None None 
Crystal C. Woodward American Diabetes Association None None None None None None 
Deborah Young-Hyman Office of Behavioral Health and Social Sciences Research, National Institutes of Health None None None None None None 
Zobair Younossi Inova Fairfax Medical Campus, Inova Health System, Falls Church, VA None None None None None None 
MemberEmploymentResearch
grant
Other
research
support
Speakers’
bureau/
honoraria
Ownership
interest
Consultant/
advisory board
Other
American Diabetes Association Professional Practice Committee 
Nuha A. ElSayed (Chair)§ American Diabetes Association None None None None Expert, World Health Organization Endocrinologist, Joslin Diabetes Center
Chair, Diabetes Education for All 
Grazia Aleppo Northwestern University Feinberg School of Medicine
Division of Endocrinology, Metabolism and Molecular Medicine 
Dexcom#, Eli Lilly#, Fractyl Health#, Insulet/Self#, Emmes# Emmes, Fractyl, Welldoc Dexcom, Insulet/Self None Bayer, Dexcom, Eli Lilly, Insulet, Medscape Associate Editor, Diabetes Technology & Therapeutics 
Vanita R. Aroda Brigham and Women’s Hospital
Faculty, Harvard Medical School 
Applied Therapeutics#, Eli Lilly#, Fractyl#, Novo Nordisk# None None None Applied Therapeutics, Fractyl, Novo Nordisk*, Pfizer, Sanofi Spouse Sandip Datta, MD, Senior Medical Director, Early Development, Infectious Diseases, May 2020 to present, Janssen Pharmaceutical Companies of Johnson & Johnson
Consultant/educational activities: Associate Editor, Diabetes Care; Member of the Writing Group for “Management of Hyperglycemia in Type 2 Diabetes, 2022. Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)”
Novo Nordisk* (received other Industry benefits, such as travel) 
Raveendhara R. Bannuru (Chief Methodologist)§ American Diabetes Association None None None None None None 
Florence M. Brown Joslin Diabetes Center None Dexcom None None None None 
Dennis Bruemmer Cleveland Clinic Lerner College of Medicine, Case Western Reserve University Novartis None None None Intellisphere, Esperion (advisory board) HCPLive/sponsored continuing medical education 
Billy S. Collins CDR, U.S. Public Health Service None None None None None None 
Marisa E. Hilliard Baylor College of Medicine Texas Children’s Hospital None JDRF None None None Springer Publishing (book royalties)
Associate Editor, American Psychological Association
Member, Clinical & Research Advisory Committee; College Diabetes Network Member, External Registry & Research Committee; T1D Exchange Mental Health Diabetes Education Program 
Diana Isaacs Cleveland Clinic Endocrinology & Metabolism Institute None None Abbott, Dexcom, Medtronic, Novo Nordisk, Bayer None Insulet, Eli Lilly, Sanofi, Klinio, Undermyfork Board of Directors, Association of Diabetes Care and Education Specialists
Clinical Practice Guideline Oversight Committee, American Association of Clinical Endocrinology 
Eric L. Johnson University of North Dakota School of Medicine and Health Sciences
Altru Health System 
None None None None None Editorial Board, Clinical Diabetes 
Scott Kahan George Washington University Milken Institute School of Public Health
National Center for Weight and Wellness 
None None None None Vivus, Eli Lilly, Novo Nordisk, Currax, Gelesis, Medscape (All without compensation)
Board of Directors, The Obesity Society Board of Directors, Obesity Action Coalition
Advocacy and Public Outreach Core Committee, Endocrine Society 
Kamlesh Khunti University of Leicester
Leicester Diabetes Centre
Leicester General Hospital 
Boehringer Ingelheim#, Applied Therapeutics, AstraZeneca#, Novartis#, Novo Nordisk#, Oramed Pharmaceuticals, Sanofi#, Eli Lilly#, Merck Sharp & Dohme# None None None AstraZeneca, Bayer, Eli Lilly, Merck Sharp & Dohme, Novartis, Novo Nordisk, Boehringer Ingelheim None 
Jose Leon National Center for Health in Public Housing None None None None None None 
Sarah K. Lyons Baylor College of Medicine
Texas Medical Center Diabetes and Endocrinology 
None None None Eli Lilly (parent stockholder) None Unpaid Board Member, Epic’s Pediatric Endocrinology Steering Board
Volunteer member, Clinical and Research Advisor Committee of College Diabetes Network
Volunteer member, Publications Committee on the T1D Exchange Quality Improvement Collaborative 
Mary Lou Perry UVA Heart and Vascular Center- Morrison’s Compass Group None None None None LifeScan Diabetes Institute Editorial Board Member, Diabetes Spectrum 
Priya Prahalad Stanford Hospital and Clinics
Lucile Packard Children’s Hospital 
None None None None None Unpaid Board Member on Epic’s Pediatric Endocrinology Steering Board 
Richard E. Pratley Advent Health Translational Research Institute Novo Nordisk# None Novo Nordisk# None Bayer AG#, Gasherbrum Bio#, Hanmi Pharmaceutical#, Hengrui (USA)#, Merck#, Novo Nordisk#, Rivus Pharmaceuticals#, Sun Pharmaceutical Industries# Editorial Board Member, Diabetes Care
Board Member, International Geriatric Diabetes Society 
Jane Jeffrie Seley Weill Cornell Medicine None None None None None Director of Strategy, Diabetes Technology Society
Associate Editor, Diabetes Spectrum
Section Co-editor, Current Diabetes Reports
Editor, Journal of Diabetes Science and Technology
Editor, BMJ Open Diabetes Research & Care
LifeScan Diabetes Institute 
Robert C. Stanton Joslin Diabetes Center None None None None None None 
Robert A. Gabbay§ American Diabetes Association None None None None Onduo*, HealthReveal, Lark, Vida Health* Spouse Christi Gabbay, CHSE, Managing Director, Major Gifts and Philanthropy at American Diabetes Association
Senior volunteer, Joslin Diabetes Center 
American College of Cardiology Designated Representatives and Staff (Section 10 “Cardiovascular Disease and Risk Management”) 
Sandeep R. Das University of Texas Southwestern Medical Center None None None None None Associate Editor, Circulation 
Mikhail Kosiborod Saint Luke’s Mid America Heart Institute AstraZeneca#, Boehringer Ingelheim# AstraZeneca# None None Alnylam, Amgen*, Applied Therapeutics#, AstraZeneca*#, Bayer*, Boehringer Ingelheim*, Cytokinetics, Eli Lilly, Esperion Therapeutics, Janssen#*, Lexicon, Merck (Diabetes and Cardiovascular), Novo Nordisk*#, Pharmacosmos, Sanofi*, Vifor Pharma*None 
American Diabetes Association Staff 
Malaika I. Hill American Diabetes Association None None None None None None 
Laura S. Mitchell American Diabetes Association None None None None None None 
Designated Subject Matter Experts 
Kenneth Cusi University of Florida Echosens#, Inventiva#, Novo Nordisk#, Poxel#, Labcorp#, and Zydus# None None None Altimmune, Arrowhead, AstraZeneca, 89Bio, Bristol-Myers Squibb, Lilly, Madrigal, Merck, Novo Nordisk, ProSciento, Quest, Sagimet Biosciences, Sonic Incytes, Terns None 
Jason L. Gaglia Joslin Diabetes Center Harvard Medical School None None None None None None 
Christopher H. Gibbons Beth Israel Deaconess Medical Center Grifols Grifols None CND Life Sciences None None 
John M. Giurini Beth Israel Deaconess Medical Center None None None None None None 
Lisa Murdock American Diabetes Association None None None None None None 
Jennifer K. Sun Joslin Diabetes Center  Novo Nordisk, Boehringer Ingelheim, Genentech/Roche Jaeb Center for Health Research/National Eye Insitute, JDRF Genentech/Roche None None 
Crystal C. Woodward American Diabetes Association None None None None None None 
Deborah Young-Hyman Office of Behavioral Health and Social Sciences Research, National Institutes of Health None None None None None None 
Zobair Younossi Inova Fairfax Medical Campus, Inova Health System, Falls Church, VA None None None None None None 
*

≥$10,000 per year from company to individual.

#

Grant or contract is to university or other employer.

Disclosure made after committee member began work on the SOC 2022 update.

§

Nuha A. ElSayed, Raveendhara R. Bannuru, and Robert A. Gabbay are also American Diabetes Association staff.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license.